Condition
Orthostatic; Hypotension, Neurogenic
Total Trials
4
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 4 (1)
Trial Status
Completed2
Recruiting1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT04782830Not ApplicableRecruitingPrimary
Use of Accelerometer for Quantification of Neurogenic Orthostatic Hypotension Symptoms
NCT04920552Not ApplicableUnknown
Abdominal Binders to Treat Orthostatic Hypotension in Parkinsonian Syndromes
NCT04858178Not ApplicableCompleted
Transcutaneous Spinal Cord Neuromodulation to Normalize Autonomic Phenotypes
NCT02308124Phase 4CompletedPrimary
Treatment and Prognosis of Neurogenic Orthostatic Hypotension : A Prospective Randomized Study
Showing all 4 trials